Analysen zu SAFRAN S.A.
| 25.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 25.10.24 | SAFRAN Neutral | UBS AG | |
| 25.10.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.10.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 14.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 08.10.24 | SAFRAN Hold | Deutsche Bank AG | |
| 08.10.24 | SAFRAN Neutral | UBS AG | |
| 27.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.09.24 | SAFRAN Kaufen | DZ BANK | |
| 11.09.24 | SAFRAN Outperform | RBC Capital Markets | |
| 06.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 03.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 02.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 22.08.24 | SAFRAN Kaufen | DZ BANK | |
| 12.08.24 | SAFRAN Hold | Deutsche Bank AG | |
| 09.08.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | SAFRAN Neutral | UBS AG | |
| 31.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 31.07.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 10.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 10.07.24 | SAFRAN Hold | Deutsche Bank AG | |
| 04.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 03.07.24 | SAFRAN Neutral | UBS AG | |
| 24.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 20.06.24 | SAFRAN Overweight | Barclays Capital | |
| 17.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 06.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 07.05.24 | SAFRAN Hold | Deutsche Bank AG | |
| 07.05.24 | SAFRAN Overweight | Barclays Capital | |
| 03.05.24 | SAFRAN Halten | DZ BANK | |
| 30.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 29.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 29.04.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.04.24 | SAFRAN Neutral | UBS AG | |
| 26.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 26.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 12.04.24 | SAFRAN Neutral | UBS AG | |
| 12.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 10.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 25.03.24 | SAFRAN Hold | Deutsche Bank AG | |
| 19.03.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 08.03.24 | SAFRAN Neutral | UBS AG | |
| 06.03.24 | SAFRAN Neutral | UBS AG | |
| 04.03.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 26.02.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 21.02.24 | SAFRAN Hold | Deutsche Bank AG | |
| 16.02.24 | SAFRAN Halten | DZ BANK | |
| 16.02.24 | SAFRAN Hold | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 16.01.26 | Gerresheimer Buy | Jefferies & Company Inc. | |
| 16.01.26 | Philips Hold | Jefferies & Company Inc. | |
| 16.01.26 | Nutrien Hold | Jefferies & Company Inc. | |
| 16.01.26 | Shell Buy | Jefferies & Company Inc. | |
| 16.01.26 | Daimler Truck Underperform | Bernstein Research | |
| 16.01.26 | BMW Buy | Deutsche Bank AG | |
| 16.01.26 | Aurubis Hold | Deutsche Bank AG | |
| 16.01.26 | Sixt Buy | Deutsche Bank AG | |
| 16.01.26 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 16.01.26 | ATOSS Software Buy | Deutsche Bank AG | |
| 16.01.26 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 16.01.26 | WACKER CHEMIE Underweight | JP Morgan Chase & Co. | |
| 16.01.26 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 16.01.26 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 16.01.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 16.01.26 | Klöckner Verkaufen | DZ BANK | |
| 16.01.26 | Evonik Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | BASF Underweight | JP Morgan Chase & Co. | |
| 16.01.26 | Glencore Outperform | RBC Capital Markets | |
| 16.01.26 | Münchener Rückversicherungs-Gesellschaft Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Bayer Neutral | UBS AG | |
| 16.01.26 | Roche Buy | UBS AG | |
| 16.01.26 | Sanofi Neutral | UBS AG | |
| 16.01.26 | GSK Neutral | UBS AG | |
| 16.01.26 | Novartis Neutral | UBS AG | |
| 16.01.26 | Sixt Buy | Warburg Research | |
| 16.01.26 | HelloFresh Equal Weight | Barclays Capital | |
| 16.01.26 | IONOS Overweight | Barclays Capital | |
| 16.01.26 | Prosus Overweight | Barclays Capital | |
| 16.01.26 | Redcare Pharmacy Overweight | Barclays Capital | |
| 16.01.26 | Scout24 Overweight | Barclays Capital | |
| 16.01.26 | Zalando Overweight | Barclays Capital | |
| 16.01.26 | AUTO1 Overweight | Barclays Capital | |
| 16.01.26 | ASOS Underweight | Barclays Capital | |
| 16.01.26 | DocMorris Equal Weight | Barclays Capital | |
| 16.01.26 | Delivery Hero Overweight | Barclays Capital | |
| 16.01.26 | Sanofi Buy | Deutsche Bank AG | |
| 16.01.26 | Diageo Outperform | Bernstein Research | |
| 16.01.26 | Roche Hold | Deutsche Bank AG | |
| 16.01.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.01.26 | GSK Hold | Deutsche Bank AG | |
| 16.01.26 | AstraZeneca Buy | UBS AG | |
| 16.01.26 | Novartis Buy | Deutsche Bank AG | |
| 16.01.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.01.26 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | London Stock Exchange Buy | Jefferies & Company Inc. | |
| 16.01.26 | Deutsche Börse Hold | Jefferies & Company Inc. | |
| 16.01.26 | JOST Werke Buy | Warburg Research | |
| 16.01.26 | freenet Equal Weight | Barclays Capital | |
| 16.01.26 | Deutsche Telekom Overweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.